CVS Health Corporation
Moat Score — CVS Health Corporation
Total Moat Score
13 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 3 / 5 | CVS's retail pharmacy brand, its roughly 9,100+ store footprint, and licensure across insurance, PBM, and pharmacy give it broad recognition, but none of this rests on patents or truly unique intellectual property. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 2 / 5 | Massive scale in drug purchasing and claims processing gives some cost leverage, but a trailing operating margin around 3% (down from ~4%) shows the advantage is thin and easily eroded by rising Medicare Advantage medical costs. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 1 / 5 | CVS has very limited pricing power: Medicare Advantage reimbursement is government-set and has risen slower than medical costs, and the PBM business faces intensifying legislative and regulatory scrutiny that constrains rebate and spread-pricing economics. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 1 / 5 | Caremark's PBM network offers a mild two-sided dynamic — more plan sponsors attract more pharmacy participation and vice versa — but this is a weak effect relative to true platform businesses and does not meaningfully deter competition from Express Scripts or OptumRx. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 3 / 5 | Employer PBM contracts, Aetna health plan enrollment cycles, and multi-year vertical integration (routing Aetna members and Caremark clients into CVS pharmacies and Oak Street clinics) create real but not insurmountable switching friction for large institutional customers. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 3 / 5 | The PBM market is concentrated among three players (Caremark, Express Scripts, OptumRx) and integrated insurer-PBM-pharmacy-provider combinations are extremely capital- and scale-intensive to replicate, giving incumbents like CVS and UnitedHealth structural protection from new entrants. |